A Study to Evaluate the Efficacy and Safety of BHV-7000 Monotherapy in Major Depressive Disorder

BHV-7000 is a drug that is being studied for for treating major depressive disorder. One way researchers think about depression is that it is caused by brain hyperactivity resulting from a combination of stress, genetics, and other environmental influences. This hyperactivity occurs on the level of the brain cells (neurons) which fire too frequently in hyperactive, depressed brains.

BHV-7000 works through supporting activity of potassium channels along a part of our neurons that can stabilize hyperactivity and balance overall electrical activity of the brain.